vancomycin has been researched along with Infectious Endophthalmitis in 303 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (2.64) | 18.7374 |
1990's | 42 (13.86) | 18.2507 |
2000's | 101 (33.33) | 29.6817 |
2010's | 113 (37.29) | 24.3611 |
2020's | 39 (12.87) | 2.80 |
Authors | Studies |
---|---|
Feghhi, M; Heidarian, A; Jounaki, K; Makhmalzadeh, BS | 1 |
Pavesio, C; Testi, I; Valdes Lara, CA | 1 |
Chaudhary, V; Garg, SJ; Patel, D; Patel, SN | 1 |
Azad, SV; Bari, A; Chawla, R; Das, U; Hasan, N; Kumar, A; Mishra, D; Satpathy, G; Velpandian, T; Venkatesh, P; Vohra, R | 1 |
Corrales, MI; Galvis, V; Garcia, D; Parra, MM; Rangel, CM; Sánchez-Ávila, R; Tello, A; Varón, CL; Villareal, E; Villarreal, D | 1 |
Agarwal, M; Gandhi, A; Mayor, R; Paul, L; Ranjan, R; Singh, S | 1 |
Horita, N; Kaneko, T; Kato, A; Masuhara, N; Mizuki, N; Namkoong, H; Nomura, E; Takeuchi, M | 1 |
Fromow-Guerra, J; Monroy-Esquivel, L; Ortiz-Guevara, R; Quiroz-Mercado, H; Velez-Montoya, R | 1 |
Fine, HF; Greenblatt, DJ; Halperin, SJ; Prenner, JL | 1 |
Cherney, EF; Daniels, AB; Kim, SJ; Law, JC; Patel, SN; Taubenslag, KJ | 1 |
Belkin, A; Dar, N; Friehmann, A; Ofir, S; Pillar, S | 1 |
Dedeker, C; Greenberg, E; Montezuma, RS; Olson, HJ | 1 |
Franklin, QJ; Kapoor, KG; Sodhi, GS; Wagner, AL | 1 |
Daibata, M; Fukuda, K; Fukushima, A; Ishida, W; Kishimoto, T; Matsuzaki, S; Nakajima, I; Suzuki, T; Todokoro, D; Uchiyama, J | 1 |
Arshinoff, SA; Felfeli, T; Modabber, M | 1 |
Bajwa, A; Khan, M; Lee, CS; Patrie, J; Shildkrot, YE | 1 |
Borque Rodríguez-Maimón, E; Garralda Luquín, A; Mozo Cuadrado, M; Tabuenca Del Barrio, L; Zubicoa Eneriz, A | 1 |
Haas, NL | 1 |
Adeli, M; Mauger, TF | 1 |
Armbrust, KR; Mammo, DA; Watson, D | 1 |
Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
Gao, L; Li, Y; Liu, G | 1 |
Balakrishnan, D; Oli, A | 1 |
Awan, MA; Muid, J | 1 |
Labetoulle, M; Poignet, B; Rousseau, A | 1 |
Campagnoli, TR; Chen, JC; Galic, IJ; Mercer, GD; Politis, M | 1 |
Ho, AC; Patel, SN; Peck, TJ | 1 |
Berry, DE; Cribbs, BE; Hendrick, A; Hubbard, GB; Jain, N; Meyer, BI; O'Keefe, G; Patel, PS; Rao, P; Shantha, JG; Yan, J; Yeh, S | 1 |
Al-Nawaiseh, S; Becker, SL; Bisorca-Gassendorf, L; Boden, KT; Januschowski, K; Pérez Guerra, N; Seitz, B | 1 |
Almeida, TC; Cardoso, JF; Da Paz, MC; Da Silva, GR; Da Silva-Cunha, A; Gil, PO; Granjeiro, PA; Klibanov, AM; Magalhães, JT; Marques, MBF; Mussel, WDN; Perasoli, FB; Silva, GND; Tavares, HDS; Toledo, CR | 1 |
Al-Lozi, A; Cai, S; Chen, X; Perez, VL; Venkateswaran, N | 1 |
Bhojwani, D | 1 |
Hamam, RN; Kallassi, L; Mansour, AM; Mehanna, CJ | 1 |
Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC | 1 |
Amer, R; Cohen, O; Corredores, J; Halpert, M | 1 |
Chen, HC; Chen, KJ; Chen, YP; Chou, HD; Hou, CH; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wang, NK; Wu, WC | 1 |
Libre, PE; Mathews, S | 1 |
Pujari, A; Singh, R; Temkar, S; Urkude, J | 1 |
Baillif, S; Butet, B; Martel, A; Martiano, D; Ramel, JC | 1 |
Bennebroek, CA; Faridpooya, K; Gan, I; Jansen, JTG; La Heij, E; Lindstedt, EW; Manning, S; Mayland Nielsen, CC; Ossewaarde-van Norel, A; Schellekens, PA; Tilanus, M; Ugahary, LC; van den Biesen, PR; van der Werf, DJ; van Dissel, JT; van Goor, AT; van Meurs, JC; van Overdam, K; Veckeneer, M; Wubbels, RJ | 1 |
Ambati, BK; Bardsley, T; Bondalapati, S; Bowen, RC; Evans, PR; Greene, T; Kliethermes, M; Lawyer, TW; Mamalis, CA; McFarland, M; Rudnisky, CJ; Shi, D; Snow, KB; Zhou, AX | 1 |
Finn, AP; Jaffe, GJ; Thompson, AC | 1 |
Cunha, GMF; Fialho, SL; Magalhães, JT; Moreira, TP; Patrício, PSO; Pereira, AF; Resende, AFC; Silva, GR; Silva-Cunha, A | 1 |
Aderman, CM; Bhisitkul, RB; Chao, DL; Chiu, CS; Obeid, A; Schwartz, DM | 1 |
Abdellaoui, T; Ajhoun, Y; Benjelloun, N; Elasri, F; Lmimouni, B; Omari, A; Oubaaz, A; Reda, K; Zerrouk, R | 1 |
Albert, DC; Brill, DA; Desai, UR; Farley, ND; Sangave, AA; Sassalos, TM | 1 |
Barrett, G; Lipsky, L | 1 |
Benton, AH; Galloway, RC; Marquart, ME; Stempak, LM | 1 |
Aoyama, Y; Arai, Y; Hoshide, S; Kabutoya, T; Kario, K; Komori, T; Oba, Y | 1 |
Campbell, JP; Flaxel, CJ; Hwang, TS; Igelman, A; Lauer, AK; Lin, P; Simonett, JM; Taylor, SC | 1 |
Braimah, IZ; Das, T; Dave, VP; Jalali, S; Mathai, A; Narayanan, R; Panchal, B; Pappuru, RR; Pathengay, A; Sharma, S; Tyagi, M | 1 |
Flynn, HW; Miller, D; Relhan, N; Stringham, JD; Yannuzzi, NA | 1 |
Lee, SJ; Lee, SU; Nam, KY; Noh, GM; Park, ID | 1 |
Chemelli, A; Glatter, O; Milak, S; Zimmer, A | 1 |
Callaway, NF; Ji, MH; Mahajan, VB; Moshfeghi, DM | 1 |
Chalam, KV; Ng, C | 1 |
Lee, SJ; Lee, SU; Nam, KY; Noh, GM | 1 |
Kassaye, SG; Lau, CY | 1 |
Gomez, T; Mitaka, H; Perlman, DC | 1 |
Chendran, P; Md Din, N; Seng Fai, T; Wan Abdul Halim, WH | 1 |
Kang, NY; Kim, EC; Kim, MS | 1 |
King, LB; Marquart, ME; Moore, QC; Norcross, EW; Sanders, ME; Taylor, S; Thompson, H; Tullos, N | 1 |
Krishnan, T; Rishi, P | 1 |
Hugo Lee, MH; Lawlor, M; Lee, AJ | 1 |
Dollin, M; Garg, SJ; Hsu, J; Pitcher, J; Reddy, S; Storey, P; Vander, J; Vojtko, J | 1 |
Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
Sharma, A; Sharma, V | 1 |
Aptel, F; Boisset, S; Brillat-Zaratzian, E; Bron, A; Chiquet, C; Cornut, PL; Maurin, M; Romanet, JP; Vandenesch, F | 1 |
Rudnisky, CJ; Wan, D; Weis, E | 1 |
Dada, T; Gupta, S; Sehgal, V; Sharma, S; Wadhwani, M | 1 |
Albini, TA; Berrocal, AM; Flynn, HW; Kuriyan, AE; Miller, D; Smiddy, WE; Weiss, KD | 1 |
Asencio, MA; Carranza, R; Celis, J; Gonzalez-del Valle, F; Huertas, M; Tenias, JM | 2 |
Bowler, IC; Gupta, A; Hornby, SJ; Orlans, HO | 1 |
Allen, P; Cassidy, D; Connell, PP; Fabinyi, DC; O'Neill, EC; Vajpayee, RB; Yeoh, J | 1 |
Alfonso, EC; Flynn, HW; Schimel, AM | 1 |
Aggarwal, H; Ahmed, S; Edwards, P; Gao, H; Kuruvilla, O; Li, Y; Qiao, X; Yee, DC | 1 |
Bhatnagar, P; Dedania, VS; Hale, BP | 1 |
Abraham, A; Ambatipudi, S; Deb-Jorder, N; Lodhi, SA; Majji, AB; Myneni, J; Pandey, N; Paruvelli, MR; Rani, A; Reddy, AK; Reddy, JM; Reddy, KR; Reddy, RR; Sahu, AK; Sinha, MK; Videkar, R | 1 |
Häberle, H; Michel, T; Pham, DT | 1 |
de Haller, R; Mavrakanas, TA; Philippe, J | 1 |
Braga-Mele, R; Chang, DF; Henderson, BA; Mamalis, N; Talley-Rostov, A; Vasavada, A | 1 |
Das, S; Dhillon, V; Rath, S; Sahu, SK; Sharma, S | 1 |
Flynn, HW; Kuriyan, AE; Miller, D; Sridhar, J | 1 |
Alpfidan, I; Demir, LS; Goktas, S; Kurtoglu, MG; Omeroglu, E; Ozcimen, M; Ozcımen, S; Saglam, F; Sakarya, R; Sakarya, Y; Yener, HI | 1 |
Falk, NS; Mali, JO; Mali, YP; Mencias, L | 1 |
Rhodes, KM; Wong, RW | 1 |
Edelsten, C; Fitzgerald, F; Harris, K; Henderson, R | 1 |
Albini, TA; Batlle, IR; Baumal, CR; Eliott, D; Engstrom, RE; Johnson, MW; Kron-Gray, MM; Leung, J; Moshfeghi, AA; Shah, AR; Sobrin, L; Witkin, AJ; Witkin, DI | 1 |
Joseph, J; Mathai, A; Nirmalkar, K; Sharma, S | 1 |
Li, ZH; Zhu, J | 1 |
Dollin, M; Fang-Yen, NH; Garg, SJ; Hsu, J; Pitcher, JD; Storey, P; Vander, J | 1 |
Carrillo-Marquez, M; Larson, KE | 1 |
Al-Abdullah, AA; Al-Falah, M; Al-Rashaed, S; Arevalo, JF; Khandekar, R | 1 |
Inaba, A; Sekiguchi, T | 1 |
Aptel, F; Boisset, S; Bron, AM; Chiquet, C; Creuzot-Garcher, C; Pechinot, A | 1 |
Fili, S; Hayvazov, S; Kohlhaas, M; Kontopoulou, K; Schilde, T | 1 |
Albini, TA; Flynn, HW; Kuriyan, AE; Miller, D; Pathengay, A; Relhan, N | 1 |
Behrooz, MJ; Sheibani, K; Soleimani, M; Tabatabaei, SA | 1 |
Chan, SQ; Mohotti, JE; Nonaka, F | 1 |
Almeida, DR; Chin, EK; Mahajan, VB | 1 |
Banta, JT; Flynn, HW; Schimel, AM; Stringham, JD | 1 |
Flynn, HW; Huang, LC; Kuriyan, AE; Leung, EH; Miller, D | 1 |
Hsing, YE; Park, J | 1 |
Ding, X; Wu, H; Xu, G; Zhang, M | 1 |
Au, CP; Healey, PR; White, AJ | 1 |
Blomquist, PH; Huang, JM; Pansick, AD | 1 |
Abbassi, S; Moisseiev, E; Park, SS | 1 |
Choragiewicz, T; Jünemann, AG; Kalinowska, A; Koss, MJ; Ksiazek, P; Maciejewski, R; Moneta-Wielgos, J; Nowomiejska, K; Rejdak, R | 1 |
Bailey, R; Haller, JA; Hark, LA; Roman, JS; Tyson, SL; Zhan, T | 1 |
Escudero, L; Olea, JL; Ramírez, C; Tarragó, R | 1 |
Khan, L; Khan, P; Mondal, P | 1 |
Lenci, LT; Miller, MA; Reddy, CV; Russell, SR | 1 |
Bala, C | 1 |
Chen, KJ; Chen, TL; Lai, CC; Sun, MH | 1 |
Ichikawa, Y; Inoue, M; Miyata, H; Shinoda, K; Sugisaka, E; Torii, H | 1 |
Chisari, G | 1 |
Cheung, BM; Kwok, AK; Liu, F | 1 |
Ho, CK; Que, TL; Tang, HH; Woo, CF; Yip, PP | 1 |
Nandi, K; Rishi, E; Rishi, P; Shroff, D; Therese, KL | 1 |
Kau, YC; Liaw, CW; Liu, SJ; Peng, YJ | 1 |
Chiquet, C; Cornut, PL | 1 |
Chen, KJ; Sun, CC; Yang, KJ; Yeung, L | 1 |
Bakri, SJ; Diago, T; Edwards, AO; McCannel, CA; Pach, JM; Pulido, JS | 1 |
Harder, B; Jonas, JB; Schlichtenbrede, FC; Spandau, UH | 1 |
Ness, T; Schneider, C | 1 |
Eghtedari, M; Hosseini, H; Saki, N; Saki, S | 1 |
Dohlman, CH; Durand, ML | 1 |
Ayres, BD; Chew, HF; Fintelmann, RE; Ho, AC; Maguire, JI | 1 |
Bahador, A; Dehghani, M; Gholami, S; Hashemi, SB; Janghorban, P; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Shishegar, M | 1 |
Cohen, JA; Davis, MJ; Dennis, RF; Epstein, RJ | 1 |
Agarwal, R; Jalali, S; Narayanan, R; Reddy, AK; Tibra, NK | 1 |
Choi, HY; Kim, SJ; Lee, JE; Lee, JS; Oum, BS | 1 |
Albini, TA; Flynn, HW; Javey, G; Kelly, KT; Moshfeghi, AA | 1 |
Crama, N; Pijl, BJ; Rentenaar, R; Theelen, T; Tilanus, MA | 1 |
Kau, YC; Liu, KS; Liu, SJ; Peng, YJ; Wen, CW | 1 |
Pierre, DJ; Tang, J | 1 |
Builles, N; Couprie, J; Devouassoux, M; Fessi, H; Hachicha, W; Hartmann, D; Kodjikian, L; Timour, Q | 1 |
Mansour, DE; Mansour, LE; Radwan, AA; Salman, AG | 1 |
Caramoy, A; Fauser, S; Kirchhof, B; Lappas, A; Schroeder, S | 1 |
Adebambo, B; Senthilvel, E; Shah, C | 1 |
Jones, DB | 1 |
Desai, RU; Pass, AB; Saffra, NA; Sharma, S | 1 |
Behera, UC; Kim, R; Shukla, D | 1 |
Nau, GJ; Potoski, BA; Sheridan, KR; Shields, RK | 1 |
Ang, M; Chee, SP; Jap, A | 1 |
Kim, JY; Kim, SY | 1 |
Balne, PK; Bhatia, K; Mathai, A; Reddy, AK; Reddy, BV; Sambhav, K | 1 |
Albrecht, E; Cook, C; Myers, L; Pollock, T; Richards, JC | 1 |
Das, T; Joseph, J; Pathengay, A; Sachdeva, V; Sharma, S | 1 |
Callegan, MC; Griffin, G; Guess, S; Leonard, R; Wheatley, NR; Wiskur, BJ; Woods, DC | 1 |
Chao, AN; Chen, KJ; Chen, YP; Hwang, YS; Wang, NK | 1 |
Bhatt, SS; Joshi, K; Stepien, KE | 1 |
Tang, RK; Tse, RK | 1 |
Brown, GC; Garg, SJ; Haller, JA; Kaiser, RS; Shah, CP; Vander, JF | 1 |
Das, MK; Koday, NK; Pathengay, A; Shah, GY | 1 |
Li, XR; Li, YX; Ma, H; Ma, WJ; Xue, ZX; Yin, HJ | 1 |
Oestreicher, JH; Wu, AY | 1 |
Flynn, HW; Goldberg, RA; Gonzalez, S; Isom, RF; Miller, D | 1 |
Chan, CC; Holland, EJ | 1 |
Bourcier, T; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A | 1 |
Hooper, CY; Khan, A; Lightman, SL; Pacheco, P; Tam, PM; Taylor, SR | 1 |
Acar, N; Bourcier, T; Gaucher, D; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A | 1 |
Davis, JL; Flynn, HW; Rachitskaya, AV | 1 |
Gopal, L; Jambulingam, M; Madhavan, HN; Rishi, E; Rishi, P; Sengupta, S; Therese, KL | 1 |
Guo, Q; Li, Z; Pi, Y; Zhu, J | 1 |
Lee, SJ; Park, I | 1 |
Herrinton, LJ; Shorstein, NH; Winthrop, KL | 1 |
Aksoy, U; Bahar, AY; Comez, A; Coskun, E; Demir, T; Erbagci, I; Gurler, B; Okumus, S; Tatar, MG; Zer, Y | 1 |
Badenoch, PR; Phipps, SE; Tamblyn, DM | 1 |
Foster, CS; Yu, EN | 1 |
Elder, MJ; Morlet, N | 1 |
Hesse, Y; Lang, GK; Spraul, CW | 1 |
Freilich, BD; Ramonas, KM | 1 |
Ahmadi, MA; Esmaeli, B; Holz, ER; Krathen, RA; Raad, II | 1 |
Subramanian, ML; Topping, TM | 1 |
Das, S; Dogra, MR; Gupta, A; Gupta, V; Narang, S; Pandav, SS | 1 |
Bui, HT; Küchle, M; Le, TM; Nguyen, NX; Nguyen, TM; Tran, TP | 1 |
THEODORE, FH | 1 |
Chin, NX; Della-Latta, P; Libre, PE | 1 |
Fujiwara, T; Hida, T; Hirakata, A; Miki, D; Nagamoto, T; Oda, H; Okada, AA; Oshitari, K | 1 |
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M | 1 |
Akgül, H; Bornfeld, N; Brockmann, C; Höck, K; Laube, T; Schilling, H; Schüler, A | 1 |
Domínguez, I; García Serrano, JL; Serrano Laborda, D | 1 |
Al-Juhaish, M; Huovinen, P; Järvinen, H; Laitinen, R; Seppälä, H | 1 |
Vedantham, V | 1 |
Zacks, DN | 1 |
Gurkan, T; Oguz, E; Oguz, H; Ozardali, I; Zeyrek, FY | 1 |
Maloof, A; Saw, V | 1 |
Burillon, C; Garweg, JG; Kodjikian, L | 1 |
Hara, Y; Shiwa, T; Umeno, K; Yoshitomi, F | 1 |
Alió, JL; Ferrer, C; Montero, J; Rodríguez, A; Ruiz-Moreno, JM | 1 |
Gandhewar, R; Khan, MY; Kumar, N | 1 |
Baglivo, E; Dang Burgener, NP; Harbarth, S; Pittet, D; Safran, AB; Sahabo, C | 1 |
Au Eong, KG; Chee, CK; Lee, JJ; Teoh, SC | 1 |
Artini, M; Costerton, JW; Missiroli, F; Nucci, C; Pasmore, M; Selan, L | 1 |
Iyer, MN; Kim, SH; Simons, KB; Wirostko, WJ | 1 |
Bucher, RS; Hall, E; Johnson, MW; Reed, DM; Richards, JE; Zacks, DN | 1 |
Chan, WM; Hui, M; Lam, DS; Liu, DT | 1 |
Gan, IM; Ugahary, LC; van Dissel, JT; van Meurs, JC | 1 |
Burillon, C; Freney, J; Garweg, JG; Kodjikian, L; Pellon, G; Renaud, FN; Roques, C | 1 |
Chen, KH; Hsu, WM; Hwu, JJ; Lai, JY; Li, YS | 1 |
Peyman, GA | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA | 1 |
Feron, E; Gan, IM; Mulder, PG; Peperkamp, E; Platenkamp, GJ; Ugahary, LC; van Dissel, JT; van Meurs, JC; Veckeneer, M | 1 |
Bacsal, K; Chee, SP | 1 |
Chang, MA; Jun, AS; Rizen, M | 1 |
Eiferman, RA; Hamrah, P; Ritterband, D; Seedor, J | 1 |
Garg, SJ; Kanitkar, K; Kleiner, R; Nelson, M | 1 |
Ball, JL; Barrett, GD | 1 |
Fessi, H; Hachicha, W; Kodjikian, L | 1 |
Sears, JE; Taban, M; Ufret-Vincenty, RL | 1 |
Al-Dhibi, H; Chaudhry, IA; Khan, AO; Shamsi, FA | 1 |
Flynn, HW; Harper, T; Miller, D | 1 |
Batterbury, M; Kaye, SB; Murphy, CC; Neal, T; Nicholson, S; Quah, SA | 1 |
Burillon, C; Casoli-Bergeron, E; Clayer-Montembault, A; Fessi, H; Freney, J; Hachicha, W; Jaafar, C; Kodjikian, L; Lee, MY | 1 |
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiyici, H; Ozturk, F | 1 |
Cheng, CK; Lee, TS; Tang, CW | 1 |
Gadia, R; Garg, S; Mehrotra, A; Nayak, N; Venkatesh, P | 1 |
Recchia, FM; Sparks, JR; Weitkamp, JH | 1 |
Libert, J | 1 |
Hu, V; Larkin, G; Muir, G; Stanford, M; Zaidi, F | 1 |
Berrocal, AM; Davis, JL; Flynn, HW; Lalwani, GA; Miller, D; Murray, TG; Quinn, CM; Scott, IU; Smiddy, WE | 1 |
Acar, N; Arevalo, JF; Dev, S; Flynn, HW; Kychenthal, A; Mittra, RA; Scott, IU; Shaikh, S | 1 |
Deramo, VA; Lai, JC; Luchs, J; Udell, IJ; Winokur, J | 1 |
Abad, JL; Alió, JL; Fernandez, J; Ferrer, C; Rodríguez, A | 1 |
Berrocal, A; Flynn, HW; Miller, D; Miller, JJ; Murray, TG; Scott, IU; Smiddy, WE | 1 |
Bali, T; Das, T; Raju, B; Rao, V; Sharma, S; Thiagarajan, G | 1 |
De Kaspar, HM; Engelbert, M; Kampik, A; Mette, M; Ta, CN; Thiel, M | 1 |
Butler, L; Durrani, OM; Konstantinos, C; Mollan, AJ; Mollan, SP | 1 |
Callegan, MC; Farrand, AJ; Novosad, BD; Robinson, ML; Wiskur, BJ | 1 |
Doft, BH | 1 |
Fiscella, RG | 2 |
Alfonso, EC; Flynn, HW | 1 |
Hall, GS; Meisler, DM; Miller, D; Pratt-Rippin, K; Roussel, TJ; Washington, JA | 1 |
Baker, AS; D'Amico, DJ; Park, SS; Ruoff, K; Samiy, N | 1 |
Aguilar, HE; Dick, J; Kincaid, M; Meredith, TA; Niesman, MR; Shaarawy, A | 1 |
Dawidex, GM; Habib, NE; Headon, MP; Malik, TY; Price, NJ | 1 |
Abe, T; Miyao, M; Ooishi, M | 1 |
McLaughlin, BJ; Mohay, J; Wood, TO | 1 |
Stern, GA | 1 |
Aaberg, TM; Flynn, HW; Murray, TG | 1 |
DeVaro, JM; Donahue, SP; Eller, AW; Jewart, BH; Kowalski, RP | 1 |
Cruess, AF; Evans, GA; Sakamoto, TK; Zoutman, DE | 1 |
Teichmann, KD | 2 |
Aguilar, HE; Dick, J; el-Massry, A; Kincaid, M; Meredith, TA; Neisman, MK; Reichley, RM; Ritchie, DJ; Shaarawy, A | 1 |
Costin, JA; Langston, RH; Meyers, SM; Townsend-Pico, WA | 1 |
Aguilar, HE; Drews, C; Gardner, S; Grossniklaus, H; Meredith, TA; Sawant, AD | 1 |
Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ | 1 |
Hiott, M; Miller, JM; Novy, C | 1 |
D'Aversa, G; Harrison, W; Mandelbaum, S; Smith, MA; Sorenson, JA; Udell, I | 1 |
Amemiya, T; Etoh, K; Ichikawa, M; Jinbayashi, H; Matsuyama, K; Ohira, A; Saitoh, A; Saitoh, AK | 1 |
Hykin, P; Lightman, S; Matheson, M; Okhravi, N; Towler, HM | 1 |
Campochiaro, PA; Haller, JA; Santos, A; Zimmer-Galler, IE | 1 |
Eliott, D; Lewis, JM | 1 |
Ayyala, RS; Fouraker, BD; Grizzard, WS; Stevens, SX | 1 |
Adamu, SA; Equi, RA; Kim, IT; Lee, GC; Mondino, BJ; Pitchekian-Halabi, H; Yoshizumi, MO | 1 |
Beigi, B; Chang, B; Jacob, J; Marsh, C; Riordan, T; Westlake, W | 1 |
Coco, RM; López, MI; Nozal, MJ; Pastor, JC | 1 |
Emi, K; Harada, J; Inoue, Y; Motokura, M; Ohji, M; Oshima, Y; Saito, Y; Tano, Y | 1 |
Kashani, A; Lee, G; Mondino, B; Palmer, J; Yoshizumi, MO | 1 |
Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
Assia, EI; Diamantstein, L; Ferencz, JR; Rubinstein, E | 1 |
D'Amico, DJ; Hong, CH; Park, SS; Ruoff, K; Vallar, RV; von Gunten, S | 1 |
Aldave, AJ; Deramo, VA; Fischer, DH; Maguire, JI; Shah, GK; Stein, JD | 1 |
Finkelman, Y; Klemperer, I; Lapid-Gortzak, R; Lifshitz, T | 1 |
Benson, WE; Brown, GC; Regillo, CD; Shah, GK; Sharma, S; Sivalingam, A; Stein, JD; Tasman, W | 1 |
Chen, JC; Roy, M | 1 |
Liu, SM; Rodrigues, M; Steidl, SM; Way, T | 1 |
Coco, RM; Lopez, MI; Pastor, JC | 1 |
De Lavalette, VW; Hooymans, JM; Van Rij, G; Versteegh, MF | 1 |
Casas, AP; Fernández, FC; Font, CC; Guijarro, JG; Quintana, AG | 1 |
Mendivil Soto, A; Mendivil, MP | 1 |
Gordon, YJ | 1 |
Jones, JB | 1 |
Kim, CY; Koh, HJ; Kwon, OW | 1 |
Bron, AJ; Haider, SA; Hassett, P | 1 |
Abu El-Asrar, AA; Kadry, AA; Shibl, AM; Tawfik, AF | 1 |
Jonas, JB | 1 |
Abreu, A; Barry, P; Cordovés, L; Seal, D | 1 |
Callegan, MC; Gilmore, MS; Parke, DW | 1 |
Ang, LP; Au Eong, KG; Lee, HM; Lim, AT; Yap, EY | 1 |
Gabriel, L; Giamarellou, H; Kavouklis, E; Kopsinis, G; Souli, M | 1 |
Beekhuis, WH; Gan, IM; Swart, W; van Dissel, JT; van Meurs, JC | 1 |
Chan, RC; Cheng, AF; Cheung, SW; Hui, M; Kwok, AK; Lam, DS; Pang, CP; Yip, CM | 1 |
Al-Torbaq, AA; Edward, DP | 1 |
Homer, P; Koziol, J; Peyman, GA; Sanders, D | 1 |
Forster, RK | 1 |
Feinberg, EB | 1 |
Gills, JP | 1 |
Borenstein, M; Miller, M; Smith, C; Smith, MA; Sorenson, JA | 1 |
Haimann, MH; Miller, JA; Weiss, H | 1 |
Baker, AS; Hemady, R | 1 |
Facklam, R; Lindquist, TD; Spika, J; Weber, K | 1 |
Carlson, AN; Cobo, LM; Kesler, JL; Stefansson, E | 1 |
Blodi, CF; Boldt, HC; Folk, JC; Pulido, JS; Weingeist, TA | 1 |
Blankenship, GW; Heilskov, T; Joondeph, BC; Olsen, KR | 1 |
Davis, JL; Flynn, HW; Forster, RK; Koidou-Tsiligianni, A; Miller, D; Pflugfelder, SC | 1 |
Harrison, W; Jakobiec, FA; Lowy, FD; Shakin, JL; Smith, MA; Sorenson, JA | 1 |
Alvarez, J; Fliesler, SJ; Forster, RK; Hernández, E; Pflugfelder, ME; Pflugfelder, SC | 1 |
Brinser, JH; Pavan, PR | 1 |
19 review(s) available for vancomycin and Infectious Endophthalmitis
Article | Year |
---|---|
Complications of intravitreal injections: 2022.
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Retina; Retinal Vasculitis; Retrospective Studies; Vancomycin | 2022 |
Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; Moxifloxacin; Network Meta-Analysis; Postoperative Complications; Vancomycin | 2022 |
ALTERNATIVE INTRAVITREAL ANTIBIOTICS: A Systematic Review for Consideration in Recalcitrant or Resistant Endophthalmitis.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Vancomycin | 2023 |
Endophthalmitis after cataract surgery: an update on recent advances.
Topics: Anti-Bacterial Agents; Cataract Extraction; Drug Implants; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Postoperative Complications; Vancomycin; Vitrectomy; Vitreous Body | 2021 |
[Microbiological and infectious disease aspects of postoperative endophthalmitis].
Topics: Anti-Bacterial Agents; Communicable Diseases; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacteria; Humans; Retrospective Studies; Vancomycin | 2021 |
Topics: Adult; Aged; Carnobacteriaceae; Diabetes Mellitus, Type 2; Endophthalmitis; Female; Humans; Keratitis; Keratoplasty, Penetrating; Valacyclovir; Vancomycin; Young Adult | 2022 |
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections, Intraocular; Intraoperative Period; Moxifloxacin; Vancomycin | 2018 |
Intracameral antibiotics for prophylaxis of postoperative endophthalmitis in Australia: a review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Australia; Cefazolin; Endophthalmitis; Humans; Injections, Intraocular; Postoperative Complications; Retinal Vasculitis; Vancomycin | 2019 |
The Early Diagnosis of Endophthalmitis Due to Group B Streptococcus Infective Endocarditis and Its Clinical Course: A Case Report and Literature Review.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Early Diagnosis; Endocarditis, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Streptococcal Infections; Streptococcus agalactiae; Treatment Outcome; Vancomycin | 2019 |
Intracameral antibiotics: Safety, efficacy, and preparation.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pharmaceutical Preparations; Treatment Outcome; Vancomycin | 2014 |
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
Topics: Anti-Bacterial Agents; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Tetracyclines; Vancomycin; Vancomycin Resistance; Visual Acuity | 2016 |
Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review.
Topics: Anti-Bacterial Agents; Drug Compounding; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glucocorticoids; Humans; Intravitreal Injections; Moxifloxacin; Phacoemulsification; Postoperative Complications; Treatment Outcome; Triamcinolone Acetonide; Vancomycin | 2017 |
Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Vancomycin; Vitrectomy | 2005 |
[Toxicity of intravitreal injections of antibiotics and antivirals].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antifungal Agents; Antiviral Agents; Ceftazidime; Endophthalmitis; Eye Infections; Ganciclovir; Humans; Injections; Vancomycin; Vitreous Body | 2007 |
Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin.
Topics: Anti-Bacterial Agents; Drug Resistance; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Postoperative Complications; Risk Factors; Therapeutic Irrigation; Vancomycin | 1995 |
Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.
Topics: Amikacin; Animals; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Postoperative Complications; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Tissue Plasminogen Activator; Vancomycin | 1993 |
Clindamycin-resistant Bacillus endophthalmitis.
Topics: Adult; Bacillaceae Infections; Bacillus; Clindamycin; Drug Resistance, Microbial; Endophthalmitis; Eye Foreign Bodies; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Vancomycin; Vitrectomy | 1993 |
Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Humans; Ophthalmology; Surgical Wound Infection; Vancomycin | 2001 |
Endogenous Klebsiella endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Endophthalmitis; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome; Vancomycin; Visual Acuity | 2000 |
12 trial(s) available for vancomycin and Infectious Endophthalmitis
Article | Year |
---|---|
A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics.
Topics: Aged; Anti-Bacterial Agents; Cataract Extraction; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Gentamicins; Glucocorticoids; Humans; Intravitreal Injections; Male; Prospective Studies; Surgical Wound Infection; Treatment Outcome; Vancomycin; Visual Acuity | 2018 |
Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aqueous Humor; Bacteria; Cataract Extraction; Ceftazidime; Chemotherapy, Adjuvant; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Filtering Surgery; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Vancomycin; Visual Acuity; Vitreous Body; Young Adult | 2011 |
Role of prophylactic intravitreal antibiotics in open globe injuries.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Endophthalmitis; Eye Injuries, Penetrating; Female; Humans; Injections; Male; Middle Aged; Prospective Studies; Vancomycin; Vitrectomy; Vitreous Body | 2003 |
Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Availability; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Half-Life; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Vancomycin; Vitreous Body | 2005 |
Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Cataract Extraction; Chemotherapy, Adjuvant; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Gentamicins; Glucocorticoids; Humans; Injections; Male; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome; Vancomycin; Vitreous Body | 2005 |
Prospective randomized controlled trial of the effect of intracameral vancomycin and gentamicin on macular retinal thickness and visual function following cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Contrast Sensitivity; Endophthalmitis; Eye Infections; Female; Follow-Up Studies; Gentamicins; Humans; Infusion Pumps; Lens Implantation, Intraocular; Macula Lutea; Male; Middle Aged; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Vancomycin; Visual Acuity | 2006 |
Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colony Count, Microbial; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye; Female; Inflammation; Methicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1997 |
The effect of intracameral, per-operative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification.
Topics: Anterior Chamber; Antibiotic Prophylaxis; Conjunctiva; Double-Blind Method; Drug Therapy, Combination; Endophthalmitis; Gentamicins; Humans; Intraoperative Care; Phacoemulsification; Postoperative Complications; Prospective Studies; Vancomycin | 1998 |
Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Amikacin; Cataract Extraction; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Female; Glucocorticoids; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2000 |
The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Aqueous Humor; Bacteria; Biological Availability; Double-Blind Method; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Half-Life; Humans; Male; Middle Aged; Phacoemulsification; Povidone-Iodine; Vancomycin | 2001 |
Vancomycin levels in human aqueous humour after intravenous and subconjunctival administration.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Conjunctiva; Endophthalmitis; Female; Fluorescent Antibody Technique; Humans; Injections, Intravenous; Male; Middle Aged; Time Factors; Vancomycin | 2001 |
Intravitreal injection of vancomycin in experimental staphylococcal endophthalmitis.
Topics: Animals; Clinical Trials as Topic; Cornea; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Endophthalmitis; Injections; Metabolic Clearance Rate; Rabbits; Retina; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin; Vitreous Body | 1975 |
272 other study(ies) available for vancomycin and Infectious Endophthalmitis
Article | Year |
---|---|
Topical ocular delivery of vancomycin loaded cationic lipid nanocarriers as a promising and non-invasive alternative approach to intravitreal injection for enhanced bacterial endophthalmitis management.
Topics: Animals; Drug Carriers; Endophthalmitis; Intravitreal Injections; Lipids; Rabbits; Vancomycin | 2021 |
Ceftazidime and Vancomycin Deposits after Intravitreal Injection in a Vitrectomized Eye.
Topics: Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Humans; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Tomography, Optical Coherence; Vancomycin; Vitrectomy | 2021 |
Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis.
Topics: Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Humans; Prospective Studies; Vancomycin | 2022 |
ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE.
Topics: Adult; Anti-Bacterial Agents; Colombia; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Imipenem; Male; Moxifloxacin; Referral and Consultation; Retrospective Studies; Vancomycin | 2022 |
Microbiological and Antibiotic Sensitivity Profile of Postoperative Endophthalmitis in a Tertiary Eye Care Hospital of North India.
Topics: Agar; Aged; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vitrectomy | 2021 |
Stability of Vancomycin and Ceftazidime With Prolonged Storage at -20°C.
Topics: Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Humans; Vancomycin | 2023 |
Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience.
Topics: Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Humans; Moxifloxacin; Retrospective Studies; Vancomycin; Vitreous Body | 2023 |
Endophthalmitis after intravitreal injections versus cataract surgery: a 15-year cohort.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Forecasting; Humans; Intravitreal Injections; Male; Middle Aged; Prognosis; Retrospective Studies; Surgical Wound Infection; Vancomycin; Visual Acuity | 2020 |
Postoperative Cataract Endophthalmitis Masquerading as Hemorrhagic Occlusive Retinal Vasculitis (HORV): A Case Report.
Topics: Aged; Anti-Bacterial Agents; Cataract Extraction; Diagnosis, Differential; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Postoperative Complications; Retinal Hemorrhage; Retinal Vasculitis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vitrectomy; Vitreous Body | 2021 |
Successful Clinical Outcome of Vancomycin-induced Hemorrhagic Occlusive Retinal Vasculitis.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Benzophenones; Bromobenzenes; Cataract Extraction; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Female; Fluorescein Angiography; Glucocorticoids; Humans; Prednisone; Retinal Hemorrhage; Retinal Vasculitis; Tomography, Optical Coherence; Valacyclovir; Vancomycin | 2021 |
Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Injections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Phage Therapy; Vancomycin; Vancomycin Resistance | 2019 |
Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Bacteria; Cataract Extraction; Cefuroxime; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Vancomycin | 2019 |
Pars Plana Vitrectomy for Endophthalmitis: Microbiologic Spectrum and Clinical Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Fluoroquinolones; Fungi; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body; Young Adult | 2021 |
Decreased painful visual acuity. Corynebacterium macginleyi blebitis-endophthalmitis infection.
Topics: Aged; Anti-Bacterial Agents; Blister; Ceftazidime; Corynebacterium; Corynebacterium Infections; Endophthalmitis; Female; Humans; Intravitreal Injections; Postoperative Complications; Time Factors; Trabeculectomy; Vancomycin; Visual Acuity | 2020 |
Fifty-two-year-old woman with painful monocular vision loss.
Topics: Diabetic Retinopathy; Endophthalmitis; Eye Pain; Female; Humans; Intravitreal Injections; Middle Aged; Vancomycin; Vision Disorders | 2020 |
Incidence of cystoid macular oedema with intracameral cephalosporin or vancomycin in cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Cephalosporins; Endophthalmitis; Female; Humans; Incidence; Injections, Intraocular; Macular Edema; Male; Middle Aged; Retrospective Studies; Vancomycin | 2020 |
Post-intravitreal injection endophthalmitis secondary to Turicella otitidis: a case report.
Topics: Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Aqueous Humor; Ceftazidime; Choroidal Neovascularization; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Male; Polymerase Chain Reaction; Postoperative Complications; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Slit Lamp Microscopy; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Mandated IOL Removal for Cure of Recurrent Enterococcus Faecalis Endophthalmitis: A Case Report.
Topics: Aged; Anti-Bacterial Agents; Device Removal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microscopy, Acoustic; Phacoemulsification; Recurrence; Slit Lamp Microscopy; Vancomycin; Visual Acuity; Vitreous Body | 2021 |
Hemorrhagic Occlusive Retinal Vasculitis Following Prophylactic Intraocular Vancomycin Injection.
Topics: Anti-Bacterial Agents; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections, Intraocular; Middle Aged; Retina; Retinal Hemorrhage; Retinal Vasculitis; Surgical Wound Infection; Vancomycin | 2020 |
Haemorrhagic occlusive retinal vasculitis caused by intravitreal vancomycin.
Topics: Anti-Bacterial Agents; Cataract Extraction; Endophthalmitis; Hemorrhage; Humans; Postoperative Complications; Retinal Vasculitis; Vancomycin | 2020 |
Intravitreal precipitation of vancomycin and ceftazidime.
Topics: Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Humans; Vancomycin | 2021 |
DELAYED-ONSET STREPTOCOCCUS INTERMEDIUS ENDOPHTHALMITIS FOLLOWING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTION.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Endothelial Growth Factors; Eye Infections, Bacterial; Female; Humans; Infant; Intravitreal Injections; Pain; Ranibizumab; Retrospective Studies; Streptococcus intermedius; Vancomycin; Vascular Endothelial Growth Factor A | 2022 |
Outcomes of Infectious Endophthalmitis in Patients with Systemic Antibiotic Allergies to Penicillins, Cephalosporins, or Vancomycin.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Hypersensitivity; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Treatment Outcome; Vancomycin | 2021 |
Vancomycin-loaded N,N-dodecyl,methyl-polyethylenimine nanoparticles coated with hyaluronic acid to treat bacterial endophthalmitis: Development, characterization, and ocular biocompatibility.
Topics: Anti-Bacterial Agents; Cell Line; Drug Carriers; Drug Liberation; Endophthalmitis; Eye; Humans; Hyaluronic Acid; Nanoparticles; Particle Size; Polyethyleneimine; Vancomycin | 2021 |
Commentary: Intravitreal moxifloxacin for acute postoperative endophthalmitis: Is it as safe and efficacious as the age-old recommended intravitreal vancomycin and ceftazidime?
Topics: Cataract; Ceftazidime; Endophthalmitis; Humans; Intravitreal Injections; Moxifloxacin; Vancomycin | 2021 |
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Streptococcus salivarius; Ultrasonography; Vancomycin; Vitrectomy; Vitreous Body | 2021 |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy | 2021 |
Bilateral Endogenous Methicillin-Resistant
Topics: Anti-Bacterial Agents; Athletes; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recovery of Function; Staphylococcal Infections; Vancomycin; Vitrectomy; Young Adult | 2021 |
Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2021 |
Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Moxifloxacin; Postoperative Complications; Vancomycin | 2017 |
Child with hypopyon.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Corneal Perforation; Diagnosis, Differential; Endophthalmitis; Eye Hemorrhage; Fluoroquinolones; Humans; Infant; Male; Moxifloxacin; Prednisolone; Ultrasonography; Vancomycin | 2017 |
Medical management of a subretinal Klebsiella pneumoniae abscess with excellent visual outcome without performing vitrectomy.
Topics: Abscess; Bacteremia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Middle Aged; Retinal Diseases; Treatment Outcome; Urinary Tract Infections; Vancomycin; Visual Acuity; Vitrectomy | 2017 |
Chronic Inflammation After YAG Capsulotomy.
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Endophthalmitis; Humans; Intravitreal Injections; Laser Therapy; Lasers, Solid-State; Lens Capsule, Crystalline; Male; Phacoemulsification; Surgical Wound Infection; Vancomycin | 2018 |
PLGA Implants containing vancomycin and dexamethasone: development, characterization and bactericidal effects.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Dexamethasone; Drug Carriers; Drug Implants; Drug Liberation; Endophthalmitis; Humans; Lactic Acid; Microbial Sensitivity Tests; Ophthalmologic Surgical Procedures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin | 2016 |
BILATERAL ENTEROCOCCUS FAECALIS ENDOPHTHALMITIS WITH MULTIPLE RECURRENCES.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Male; Microscopy, Electron; Recurrence; Secondary Prevention; Ultrasonography; Vancomycin; Visual Acuity; Vitrectomy | 2021 |
[Endophthalmitis secondary to keratomycosis of unusual etiology: Scytalidium hyalinum].
Topics: Administration, Oral; Ascomycota; Ceftazidime; Diabetes Mellitus, Type 2; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Middle Aged; Mitosporic Fungi; Vancomycin; Voriconazole | 2018 |
BILATERAL ENDOGENOUS ENDOPHTHALMITIS FROM STREPTOCOCCUS PNEUMONIAE.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Male; Middle Aged; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin; Visual Acuity; Vitreous Body | 2021 |
Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Erythrocytes; Humans; Microbial Sensitivity Tests; Sheep; Vancomycin; Viridans Streptococci; Virulence; Virulence Factors | 2018 |
Culture-Proven Endophthalmitis After Intravitreal Injection: A 10-Year Analysis.
Topics: Aged; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Forecasting; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2019 |
ENTEROCOCCUS ENDOPHTHALMITIS: Clinical Settings, Antimicrobial Susceptibility, and Management Outcomes.
Topics: Adult; Anti-Bacterial Agents; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity; Vitreous Body | 2020 |
Coagulase-negative Staphylococcus isolates causing endophthalmitis: Changing patterns of vancomycin susceptibilities.
Topics: Anti-Bacterial Agents; Coagulase; Endophthalmitis; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Vancomycin | 2019 |
Recurrent
Topics: Aged; Dexamethasone; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Recurrence; Vancomycin; Vitreous Body | 2019 |
Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Diffusion; Drug Liberation; Endophthalmitis; Eye; Glycerides; Intravitreal Injections; Liquid Crystals; Phase Transition; Vancomycin | 2019 |
Bilateral Endophthalmitis after Immediately Sequential Bilateral Cataract Surgery.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Ceftazidime; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin; Vitrectomy; Vitreous Body | 2019 |
Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Combinations; Drug Implants; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin, Dexamethasone Drug Combination; Triamcinolone; Vancomycin; Vitrectomy | 2020 |
Precipitation of Vancomycin and Ceftazidime on Intravitreal Injection in Endophthalmitis Patients.
Topics: Aged; Anti-Bacterial Agents; Chemical Precipitation; Drug Interactions; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Slit Lamp Microscopy; Vancomycin | 2019 |
Listeria endophthalmitis in a patient receiving immunomodulatory therapy.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Immunological; Endophthalmitis; Eye Infections, Bacterial; Gastrointestinal Agents; Humans; Immunomodulation; Infliximab; Listeria monocytogenes; Male; Melanoma; Nivolumab; Vancomycin; Vitrectomy | 2019 |
Scleritis and Endophthalmitis Due to Streptococcus pyogenes Infective Endocarditis.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Echocardiography; Endocarditis, Bacterial; Endophthalmitis; Humans; Intravitreal Injections; Magnetic Resonance Imaging; Male; Mitral Valve; Mitral Valve Insufficiency; Scleritis; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2020 |
Pyogenic Granuloma Formation Following Ahmed Valve Glaucoma Implant.
Topics: Aged; Anti-Bacterial Agents; Device Removal; Endophthalmitis; Eye Infections, Bacterial; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Granuloma, Pyogenic; Humans; Intraocular Pressure; Male; Microbial Sensitivity Tests; Prosthesis Implantation; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2019 |
Fungal corneal ulcer and bacterial orbital cellulitis occur as complications of bacterial endophthalmitis after cataract surgery in an immunocompetent patient.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cataract Extraction; Ceftazidime; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Immunocompetence; Intravitreal Injections; Male; Middle Aged; Orbital Cellulitis; Pneumococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2013 |
Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Colony Count, Microbial; Disease Models, Animal; Electroretinography; Endophthalmitis; Immunization, Passive; Pneumococcal Infections; Pneumococcal Vaccines; Rabbits; Streptococcus pneumoniae; Streptolysins; Vancomycin | 2013 |
Management of a case of Candida endogenous endophthalmitis in a neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Candida tropicalis; Candidemia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Infant, Newborn; Intravitreal Injections; Pyrimidines; Triazoles; Vancomycin; Voriconazole | 2014 |
Abiotrophia defectiva bleb-associated endophthalmitis confirmed with 16s ribosomal RNA sequencing.
Topics: Abiotrophia; Aged; Anti-Bacterial Agents; Atropine; Ceftazidime; Cephalothin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Mydriatics; Phacoemulsification; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S; Surgically-Created Structures; Trabeculectomy; Vancomycin; Vitreous Body | 2015 |
The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Topics: Administration, Topical; Aged; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Case-Control Studies; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Ophthalmic Solutions; Retinal Diseases; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body | 2014 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
From the toe to the head: metastatic endophalmitis following staphylococcal purpura fulminans.
Topics: Adult; Anti-Bacterial Agents; Endophthalmitis; Humans; Male; Purpura Fulminans; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Outcome; Vancomycin | 2014 |
FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Aqueous Humor; Ceftazidime; DNA, Bacterial; DNA, Ribosomal; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Female; Filtering Surgery; Glaucoma; Gram-Positive Bacterial Infections; Humans; Male; Polymerase Chain Reaction; Postoperative Complications; RNA, Ribosomal, 16S; Streptococcal Infections; Streptococcus; Vancomycin; Vitreous Body | 2014 |
Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis.
Topics: Aged; Aged, 80 and over; Alberta; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Case-Control Studies; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Hospitals, Private; Hospitals, Public; Humans; Incidence; Male; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Vancomycin | 2014 |
Blebitis with scleral abscess in a case of operated trabeculectomy with mitomycin C and a subcunjunctival ologen implant.
Topics: Abscess; Alkylating Agents; Anti-Bacterial Agents; Ceftriaxone; Collagen; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glaucoma, Open-Angle; Glycosaminoglycans; Humans; Male; Mitomycin; Prostheses and Implants; Scleral Diseases; Staphylococcal Infections; Trabeculectomy; Vancomycin; Young Adult | 2014 |
Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Viridans Streptococci; Visual Acuity; Vitrectomy; Young Adult | 2014 |
Impact of changes in antibiotic prophylaxis on postoperative endophthalmitis in a Spanish hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gentamicins; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Regression Analysis; Retrospective Studies; Spain; Vancomycin | 2014 |
A case-control study of post-operative endophthalmitis diagnosed at a Spanish hospital over a 13-year-period.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Case-Control Studies; Cataract Extraction; Endophthalmitis; Female; Gentamicins; Hospitals; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Spain; Vancomycin; Young Adult | 2015 |
Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Aqueous Humor; Bacteria; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; United Kingdom; Vancomycin; Visual Acuity; Vitreous Body | 2014 |
Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Bacteria; Ceftazidime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Evisceration; Eye Infections, Bacterial; Female; Humans; Incidence; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Vancomycin; Visual Acuity | 2014 |
Endophthalmitis prophylaxis for cataract surgery: are intracameral antibiotics necessary?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Gentamicins; Humans; Vancomycin | 2014 |
Intraocular penetration of systemic antibiotics in eyes with penetrating ocular injury.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Corneal Injuries; Endophthalmitis; Eye Injuries, Penetrating; Fluoroquinolones; Gram-Positive Bacterial Infections; Intravitreal Injections; Moxifloxacin; Rabbits; Sclera; Vancomycin; Vitreous Body | 2014 |
Endogenous endophthalmitis due to clinically vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2015 |
Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?
Topics: Adult; Anti-Bacterial Agents; Aqueous Humor; Bacteria; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin; Vitreous Body | 2015 |
[Follow-up of postoperative endophthalmitis after cataract surgery and intravitreal injection of drugs - an analysis since 2009].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Surgical Procedures; Anti-Inflammatory Agents; Bevacizumab; Cataract Extraction; Drug Resistance, Microbial; Endophthalmitis; Gentamicins; Humans; Intravitreal Injections; Middle Aged; Postoperative Complications; Ranibizumab; Retinal Detachment; Retrospective Studies; Silicone Oils; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy | 2015 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmitis; Female; Foot Diseases; Humans; Imipenem; Osteomyelitis; Radiography; Vancomycin | 2015 |
Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India.
Topics: Adolescent; Adult; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Cefuroxime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Injections, Intraocular; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Prospective Studies; Vancomycin | 2015 |
ENDOPHTHALMITIS CAUSED BY PSEUDOMONAS AERUGINOSA: Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin; Visual Acuity; Vitreous Body | 2015 |
Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Intravitreal Injections; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Vancomycin | 2016 |
Endogenous endophthalmitis with iris abscess after routine dental cleaning.
Topics: Abscess; Acute Disease; Anti-Bacterial Agents; Clindamycin; Dental Care; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Iris Diseases; Middle Aged; Streptococcal Infections; Streptococcus intermedius; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Endophthalmitis caused by Staphylococcus hominis and two different colonies of Staphylococcus haemolyticus after cataract surgery.
Topics: Anti-Bacterial Agents; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Middle Aged; Staphylococcal Infections; Staphylococcus haemolyticus; Staphylococcus hominis; Surgical Wound Infection; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2015 |
Group A streptococcal endophthalmitis complicating a sore throat in a 2-year-old child.
Topics: Anti-Bacterial Agents; Child, Preschool; Clindamycin; Diagnosis, Differential; Endophthalmitis; Female; Humans; Orbital Cellulitis; Pharyngitis; Polymerase Chain Reaction; Radiography; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome; Ultrasonography; Vancomycin | 2015 |
Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.
Topics: Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Female; Fluorescein Angiography; Glaucoma, Neovascular; Humans; Intravitreal Injections; Laser Coagulation; Male; Middle Aged; Postoperative Complications; Retinal Hemorrhage; Retinal Vasculitis; Retrospective Studies; Tomography, Optical Coherence; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Clinical features, microbiological profile and treatment outcome of patients with Corynebacterium endophthalmitis: review of a decade from a tertiary eye care centre in southern India.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Corynebacterium; Corynebacterium Infections; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Vancomycin | 2016 |
Clinical features and treatment of endophthalmitis after cataract surgery.
Topics: Adult; Aged; Cataract; Cataract Extraction; Ceftazidime; Endophthalmitis; Female; Humans; Intravitreal Injections; Male; Middle Aged; Vancomycin; Vitrectomy | 2015 |
MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bacteria; Ceftazidime; Drug Combinations; Drug Substitution; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis after leg trauma.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Bacteremia; Basketball; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Leg Injuries; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2015 |
Endophthalmitis Caused by Rhizobium radiobacter After Posterior Chamber Phakic Intraocular Lens Implantation to Correct Myopia.
Topics: Acute Disease; Administration, Topical; Adult; Agrobacterium tumefaciens; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Myopia; Phakic Intraocular Lenses; Postoperative Complications; Vancomycin; Vitreous Body | 2015 |
Endogenous Endophthalmitis Following Streptococcus pneumoniae Meningitis.
Topics: Aged; Anti-Bacterial Agents; Blindness; Blood-Retinal Barrier; Ceftriaxone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2015 |
Massilia timonae as cause of chronic endophthalmitis following cataract surgery.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Chronic Disease; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Microbial Sensitivity Tests; Oxalobacteraceae; Phacoemulsification; Polymerase Chain Reaction; Postoperative Complications; RNA, Ribosomal, 16S; Tobramycin; Vancomycin | 2015 |
[Low grade endophthalmitis caused by P. acnes : Case report].
Topics: Aged, 80 and over; Amikacin; Combined Modality Therapy; Diagnosis, Differential; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Lenses, Intraocular; Postoperative Complications; Propionibacterium acnes; Vancomycin; Vitrectomy | 2016 |
SYSTEMIC ORAL ANTIBIOTICS AS A PROPHYLACTIC MEASURE TO PREVENT ENDOPHTHALMITIS IN PATIENTS WITH OPEN GLOBE INJURIES IN COMPARISON WITH INTRAVENOUS ANTIBIOTICS.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Vancomycin; Visual Acuity; Young Adult | 2016 |
A case of bilateral endogenous bacterial endophthalmitis from Streptococcus pneumoniae bacteraemia.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Azithromycin; Bacteremia; Drug Therapy, Combination; Endophthalmitis; Female; Humans; Hypercholesterolemia; Hypertension; Middle Aged; Patient Transfer; Penicillin G; Risk Factors; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Vitrectomy | 2016 |
Chronic Recurrent Pseudophakic Endophthalmitis.
Topics: Aged, 80 and over; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Female; Follow-Up Studies; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Recurrence; Risk Assessment; Slit Lamp; Treatment Outcome; Vancomycin; Vitrectomy | 2016 |
Dropless Cataract Surgery: What Are the Potential Downsides?
Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Lens Implantation, Intraocular; Moxifloxacin; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Risk Factors; Triamcinolone; Vancomycin | 2016 |
Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteria; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Female; Glaucoma; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
Haemorrhagic occlusive retinal vasculitis associated with intracameral vancomycin during cataract surgery.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Laser Coagulation; Postoperative Complications; Retinal Hemorrhage; Retinal Vasculitis; Tomography, Optical Coherence; Vancomycin | 2016 |
Pediatric posttraumatic endophthalmitis.
Topics: Anti-Bacterial Agents; Bacteria; Ceftazidime; Child; Child, Preschool; Corneal Injuries; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Female; Follow-Up Studies; Humans; Intravitreal Injections; Male; Retrospective Studies; Sclera; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2016 |
Efficacy and cost-effectiveness of intracameral vancomycin in reducing postoperative endophthalmitis incidence in Australia.
Topics: Acute Disease; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Australia; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity | 2016 |
Use of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe Injury.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2016 |
Intravitreal dexamethasone in the management of acute endophthalmitis: a comparative retrospective study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftazidime; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body; Young Adult | 2017 |
Vancomycin in infusion during vitrectomy in surgical treatment of acute postoperative and posttraumatic endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Staphylococcus; Streptococcus; Vancomycin; Visual Acuity; Vitrectomy; Young Adult | 2016 |
Endophthalmitis after intravitreal injections. Incidence, management and prognosis.
Topics: Aged, 80 and over; Blindness; Combined Modality Therapy; Diabetes Complications; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intravitreal Injections; Male; Micrococcus; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Prognosis; Retinal Detachment; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vitrectomy | 2017 |
Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bevacizumab; Ceftazidime; Cluster Analysis; Drug Contamination; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Middle Aged; Retinal Diseases; Risk Factors; Vancomycin; Young Adult | 2016 |
Postoperative hemorrhagic occlusive retinal vasculitis associated with intracameral vancomycin prophylaxis during cataract surgery.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Postoperative Complications; Retinal Vasculitis; Vancomycin | 2016 |
Intracameral antibiotic: the Vancomycin conundrum.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Endophthalmitis; Humans; Incidence; Retinal Hemorrhage; Retinal Vasculitis; Vancomycin | 2016 |
Endophthalmitis: antibacterial activity of precipitates of vancomycin and ceftazidime.
Topics: Anti-Bacterial Agents; Ceftazidime; Chemical Precipitation; Endophthalmitis; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Treatment Outcome; Vancomycin | 2008 |
Bilateral endophthalmitis in a patient with bacterial meningitis caused by Streptococcus pneumoniae.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftazidime; Cerebrospinal Fluid; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Functional Laterality; Humans; Male; Meningitis, Pneumococcal; Retinal Detachment; Scleral Buckling; Streptococcus pneumoniae; Vancomycin; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2008 |
Endophthalmitis: gram positive ethiological agents and susceptibility to glycopeptides.
Topics: Anti-Bacterial Agents; Bacillus; Endophthalmitis; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Peptococcus; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 2008 |
The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Choroid Diseases; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Gram-Positive Bacterial Infections; Injections; Iridocyclitis; Rabbits; Treatment Outcome; Vancomycin; Vasculitis; Vitreous Body | 2008 |
Methicillin-resistant Staphylococcus aureus endophthalmitis after phacoemulsification in a continuous ambulatory peritoneal dialysis patient.
Topics: Aged; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Peritoneal Dialysis, Continuous Ambulatory; Phacoemulsification; Postoperative Complications; Staphylococcal Infections; Vancomycin; Vitreous Body | 2008 |
Endophthalmitis caused by Enterococcus faecalis: a case series.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2009 |
In vitro elution of vancomycin/amikacin/steroid from solvent-free biodegradable scleral plugs.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Drug Stability; Drug Therapy, Combination; Endophthalmitis; Escherichia coli; Glucocorticoids; Lactic Acid; Microbial Sensitivity Tests; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sclera; Staphylococcus aureus; Vancomycin | 2009 |
[Intravitreal injection of antibiotics in endophthalmitis].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Humans; Injections; Retinal Detachment; Vancomycin; Vitrectomy; Vitreous Body | 2008 |
Traumatic endophthalmitis caused by Enterococcus raffinosus and Enterobacter gergoviae.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Endophthalmitis; Enterobacter; Enterobacteriaceae Infections; Enterococcus; Eye Injuries, Penetrating; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin; Wound Infection | 2009 |
Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections; Female; Humans; Injections; Male; Ranibizumab; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin; Vitreous Body | 2009 |
Lens capsular bag irrigation for low-grade endophthalmitis.
Topics: Anti-Bacterial Agents; Drainage; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Humans; Isotonic Solutions; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Phacoemulsification; Postoperative Complications; Retrospective Studies; Ringer's Solution; Therapeutic Irrigation; Treatment Outcome; Vancomycin; Visual Acuity | 2009 |
Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Blindness; Endophthalmitis; Eye Enucleation; Eye Infections, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitreous Body | 2009 |
Aspergillus endophthalmitis in orthotopic liver transplantation.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Ceftazidime; Endophthalmitis; Eye; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Ophthalmologic Surgical Procedures; Ophthalmoscopy; Transplantation, Homologous; Ultrasonography; Vancomycin; Young Adult | 2009 |
Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cicatrix; Cornea; Corneal Transplantation; Endophthalmitis; Equipment Design; Eye Burns; Eye Diseases; Follow-Up Studies; Graft Rejection; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Incidence; Mycobacterium Infections, Nontuberculous; Pemphigoid, Benign Mucous Membrane; Prosthesis Implantation; Prosthesis-Related Infections; Retrospective Studies; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome; Vancomycin | 2009 |
Characteristics of endophthalmitis in patients with the Boston keratoprosthesis.
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Coagulase; Cornea; Drug Resistance, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Fluoroquinolones; Humans; Incidence; Injections, Intravenous; Prosthesis Implantation; Prosthesis-Related Infections; Pseudomonas; Pseudomonas Infections; Retinal Diseases; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin; Vitreous Body | 2009 |
Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus; Endophthalmitis; Eye Enucleation; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymerase Chain Reaction; Pyrimidines; Triazoles; Vancomycin; Voriconazole; Young Adult | 2009 |
Culture-positive endophthalmitis after implantation of intraocular Collamer lens.
Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Glucocorticoids; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microsurgery; Postoperative Complications; Prednisolone; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Visual Acuity; Vitreous Body | 2009 |
Traumatic endophthalmitis caused by Staphylococcus gallinarum.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Endophthalmitis; Humans; Male; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin; Vitrectomy; Wounds and Injuries | 2010 |
Endophthalmitis caused by Pseudomonas aeruginosa after phakic posterior chamber intraocular lens implantation to correct high myopia.
Topics: Ceftazidime; Cyclopentolate; Device Removal; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Myopia, Degenerative; Phakic Intraocular Lenses; Posterior Eye Segment; Postoperative Complications; Pseudomonas Infections; Vancomycin; Visual Acuity; Vitrectomy; Young Adult | 2011 |
Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics.
Topics: Anti-Bacterial Agents; Ceftazidime; Chemical Precipitation; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Hydrogen-Ion Concentration; Macular Edema; Middle Aged; Tomography, Optical Coherence; Vancomycin; Vitreous Body | 2010 |
Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftazidime; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Phacoemulsification; Postoperative Complications; Referral and Consultation; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body; Young Adult | 2010 |
Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biocompatible Materials; Dexamethasone; Drug Carriers; Drug Delivery Systems; Endophthalmitis; Lactic Acid; Materials Testing; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Sclera; Solvents; Vancomycin | 2010 |
Bleb associated endophthalmitis with methicillin-resistant Staphylococcus aureus.
Topics: Aged; Anti-Bacterial Agents; Endophthalmitis; Filtering Surgery; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Postoperative Complications; Staphylococcal Infections; Vancomycin | 2010 |
Experimental intracameral injection of vancomycin microparticles in rabbits.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cell Count; Chromatography, High Pressure Liquid; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Endothelium, Corneal; Eye Infections, Bacterial; Half-Life; Injections; Iris; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Particle Size; Polyglactin 910; Rabbits; Retina; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2010 |
Polymerase chain reaction in pediatric post-traumatic fungal endophthalmitis among Egyptian children.
Topics: Adolescent; Aspergillosis; Candidiasis; Child; Corneal Ulcer; Egypt; Endophthalmitis; Eye Infections, Fungal; Eye Injuries; Fungi; Humans; Male; Polymerase Chain Reaction; Prospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2010 |
Intraocular inflammation after intravitreal ranibizumab injections.
Topics: Aged; Angiogenesis Inhibitors; Anterior Chamber; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Ranibizumab; Retreatment; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2011 |
Red eye, blurry vision, and cough.
Topics: Anti-Infective Agents; Aortic Valve; Aortic Valve Insufficiency; Aza Compounds; Blindness; Ceftriaxone; Cough; Echocardiography, Transesophageal; Endophthalmitis; Fever; Fluoroquinolones; Hearing Loss, Sensorineural; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Moxifloxacin; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae; Vancomycin; Vision Disorders | 2010 |
Emerging vancomycin resistance: what are we waiting for?
Topics: Endophthalmitis; Enterococcus faecium; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Phacoemulsification; Vancomycin; Vancomycin Resistance | 2010 |
Vancomycin-resistant enterococcal endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecium; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Phacoemulsification; Vancomycin; Vancomycin Resistance; Vitrectomy | 2010 |
In their patient, as in our patient, vitreous specimens were culture negative.
Topics: Anti-Bacterial Agents; Ceftazidime; Chemical Precipitation; Endophthalmitis; Eye Infections, Bacterial; Humans; Hydrogen-Ion Concentration; Macular Edema; Tomography, Optical Coherence; Vancomycin; Vitreous Body | 2010 |
Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
Topics: Anti-Bacterial Agents; Daptomycin; Endophthalmitis; Female; Humans; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin; Vitreous Body | 2010 |
Prognostic factors and outcomes in endogenous Klebsiella pneumoniae endophthalmitis.
Topics: Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Vancomycin; Visual Acuity; Vitreous Body | 2011 |
Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intravenous; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2011 |
Endogenous endophthalmitis caused by Enterococcus casseliflavus.
Topics: Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Recurrence; Vancomycin; Vitrectomy; Young Adult | 2011 |
Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Child; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity | 2011 |
Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Combined Modality Therapy; Disease Models, Animal; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Leukocyte Count; Male; Neutrophils; Rabbits; Retina; Specific Pathogen-Free Organisms; Treatment Outcome; Vancomycin; Vitrectomy; Vitreous Body | 2011 |
Prognostic factors and outcomes in endogenous Klebsiella endophthalmitis.
Topics: Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors; Vancomycin; Visual Acuity; Vitreous Body | 2011 |
Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bacteria; Bevacizumab; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vancomycin; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
Acute renal failure after topical fortified gentamicin and vancomycin eyedrops.
Topics: Acute Kidney Injury; Administration, Topical; Aged; Anti-Bacterial Agents; Endophthalmitis; Female; Gentamicins; Humans; Ophthalmic Solutions; Vancomycin | 2011 |
Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Case-Control Studies; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Ranibizumab; Retrospective Studies; Risk Factors; Tobramycin; Treatment Outcome; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2011 |
Vancomycin-resistant coagulase negative Staphylococcus endophthalmitis following cataract surgery.
Topics: Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Phacoemulsification; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Vitreous Body | 2011 |
Antiinflammatory effect of low-level laser therapy on Staphylococcus epidermidis endophthalmitis in rabbits.
Topics: Animals; Combined Modality Therapy; Dexamethasone; Endophthalmitis; Lasers, Semiconductor; Low-Level Light Therapy; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Tumor Necrosis Factor-alpha; Ultrasonography; Vancomycin | 2012 |
Endogenous bacterial endophthalmitis after routine colonoscopy.
Topics: Aged; Blindness; Ceftazidime; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Escherichia coli; Escherichia coli Infections; Eye Infections, Bacterial; Female; Humans; Orbital Cellulitis; Phacoemulsification; Vancomycin; Vitrectomy | 2011 |
An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Disease Outbreaks; Drug Compounding; Drug Contamination; Endophthalmitis; Eye Infections, Bacterial; Female; Florida; Humans; Intravitreal Injections; Male; Streptococcal Infections; Streptococcus mitis; Streptococcus oralis; Vancomycin; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2012 |
Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation.
Topics: Administration, Oral; Aged; Amphotericin B; Artificial Organs; Candida albicans; Candidiasis; Ceftazidime; Cornea; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Incidence; Intravitreal Injections; Middle Aged; Ochrobactrum anthropi; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Reoperation; Retrospective Studies; Vancomycin; Vitreous Body; Young Adult | 2012 |
Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Colony Count, Microbial; Daptomycin; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Eye; Female; Half-Life; Intravitreal Injections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Severity of Illness Index; Staphylococcal Infections; Vancomycin | 2012 |
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; Cataract Extraction; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body | 2012 |
Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Electroretinography; Endophthalmitis; Female; Intravitreal Injections; Linezolid; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2012 |
Endogenous endophthalmitis caused by salmonella serotype B in an immunocompetent 12-year-old child.
Topics: Anti-Bacterial Agents; Ceftazidime; Child; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Feces; Humans; Immunocompetence; Male; Meropenem; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Vancomycin; Visual Acuity; Vitreous Body | 2012 |
Acute postoperative Bacillus cereus endophthalmitis mimicking toxic anterior segment syndrome.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aqueous Humor; Bacillus cereus; Ceftazidime; Diagnosis, Differential; Drug Therapy, Combination; Endophthalmitis; Endotoxemia; Eye Evisceration; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Keratoplasty, Penetrating; Lens Implantation, Intraocular; Male; Microbial Sensitivity Tests; Middle Aged; Phacoemulsification; Postoperative Complications; Retrospective Studies; Uveitis, Anterior; Vancomycin | 2013 |
Clinical analysis of cataract surgery complicated by endophthalmitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Staphylococcus; Staphylococcus epidermidis; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2012 |
Factors affecting precipitation of vancomycin and ceftazidime on intravitreal injection.
Topics: Anti-Bacterial Agents; Ceftazidime; Chemical Precipitation; Diffusion; Endophthalmitis; Humans; Intravitreal Injections; Temperature; Vancomycin | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; California; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Incidence; Lens Implantation, Intraocular; Moxifloxacin; Phacoemulsification; Postoperative Complications; Quinolines; Vancomycin | 2013 |
Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Daptomycin; Endophthalmitis; Eye; Intravitreal Injections; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Vancomycin | 2013 |
Capnocytophaga canimorsus endophthalmitis following cataract surgery.
Topics: Aged; Aged, 80 and over; Capnocytophaga; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Lens Implantation, Intraocular; Male; Phacoemulsification; Vancomycin; Visual Acuity; Vitreous Body | 2002 |
Chronic postoperative endophthalmitis due to pseudomonas oryzihabitans.
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Device Removal; Diagnosis, Differential; Endophthalmitis; Eye; Humans; Injections; Lens Capsule, Crystalline; Lenses, Intraocular; Male; Pseudomonas; Pseudomonas Infections; Surgical Wound Infection; Treatment Failure; Uveitis; Vancomycin | 2002 |
Endophthalmitis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aqueous Humor; Bacteria; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Vancomycin; Vitrectomy; Vitreous Body | 2002 |
[Endophthalmitis following cataract surgery].
Topics: Amikacin; Cefotaxime; Ceftazidime; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lenses, Intraocular; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy | 2002 |
Iris abscess as an unusual presentation of endogenous endophthalmitis in a patient with bacterial endocarditis.
Topics: Abscess; Adult; Anterior Chamber; Bacteremia; Ceftazidime; Dexamethasone; Drug Therapy, Combination; Endocarditis, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Humans; Iris Diseases; Male; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2003 |
Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection.
Topics: Aged; Bacteremia; Endophthalmitis; Enterococcus faecium; Eye Enucleation; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance; Vitrectomy | 2003 |
Endogenous endophthalmitis after routine dental cleaning.
Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Middle Aged; Oral Hygiene; Streptococcal Infections; Streptococcus; Vancomycin; Vitrectomy; Vitreous Body | 2003 |
[Post-traumatic endophthalmitis after penetrating injury in Vietnam: risk factors, microbiological aspect and visual outcome].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Injuries, Penetrating; Female; Follow-Up Studies; Gentamicins; Humans; Injections; Male; Middle Aged; Military Personnel; Retrospective Studies; Risk Factors; Vancomycin; Vietnam; Visual Acuity; Vitreous Body | 2003 |
TREATMENT OF BACTERIAL ENDOPHTHALMITIS FOLLOWING CATARACT EXTRACTION.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Cataract Extraction; Chloramphenicol; Endophthalmitis; Methicillin; Novobiocin; Oxacillin; Postoperative Complications; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptomycin; Tetracycline; Toxicology; Vancomycin | 1964 |
Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model.
Topics: Anti-Bacterial Agents; Endophthalmitis; Enzyme Inhibitors; Eye; Half-Life; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin | 2003 |
[Vitrectomy for endophthalmitis after cataract surgery].
Topics: Aged; Aged, 80 and over; Cataract Extraction; Endophthalmitis; Female; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Visual Acuity; Vitrectomy | 2003 |
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Amikacin; Animals; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2004 |
[Endogenous bacterial endophthalmitis: a retrospective study on 22 consecutive cases].
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Causality; Combined Modality Therapy; Endophthalmitis; Eye Enucleation; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Vancomycin; Vitrectomy; Vitreous Body | 2004 |
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Keratoplasty, Penetrating; Male; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2004 |
Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Chloramphenicol; Chloramphenicol Resistance; Conjunctiva; Drug Therapy, Combination; Endophthalmitis; Humans; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Surgical Wound Infection; Vancomycin; Vancomycin Resistance; Viridans Streptococci | 2004 |
Ciprofloxacin in endophthalmitis: an emerging alternative.
Topics: Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Vancomycin | 2004 |
Neisseria meningitidis endophthalmitis.
Topics: Adolescent; Ceftazidime; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Meningococcal Infections; Neisseria meningitidis; Polymerase Chain Reaction; Vancomycin; Vitreous Body | 2004 |
Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits.
Topics: Animals; Anti-Infective Agents, Local; Ciliary Body; Colony Count, Microbial; Endophthalmitis; Eye Infections, Bacterial; Injections; Microbial Sensitivity Tests; Povidone; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Taurine; Thiadiazines; Vancomycin; Vitreous Body | 2004 |
Prophylactic intracameral vancomycin.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Endophthalmitis; Humans; Vancomycin | 2004 |
Intracameral vancomycin and endophthalmitis prophylaxis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Endophthalmitis; Humans; Methicillin Resistance; Staphylococcal Infections; Vancomycin | 2004 |
Post-cataract surgery endophthalmitis treated with core vitrectomy: a case report.
Topics: Aged; Anti-Bacterial Agents; Cataract Extraction; Endophthalmitis; Female; Humans; Injections, Intralesional; Postoperative Complications; Staphylococcal Infections; Treatment Outcome; Vancomycin; Vitrectomy | 2004 |
Postoperative Corynebacterium macginleyi endophthalmitis.
Topics: Aged; Aqueous Humor; Bacterial Typing Techniques; Cataract Extraction; Chronic Disease; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gene Amplification; Humans; Lens Implantation, Intraocular; Male; Ofloxacin; Polymerase Chain Reaction; Postoperative Complications; Tobramycin; Vancomycin; Vitreous Body | 2004 |
Serratia marcescens endophthalmitis after cataract surgery despite vancomycin and gentamicin in irrigation fluid.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Bacterial; Gentamicins; Humans; Male; Phacoemulsification; Postoperative Complications; Serratia Infections; Serratia marcescens; Therapeutic Irrigation; Vancomycin; Vitreous Body | 2004 |
Pasteurella multocida endophthalmitis: case report and review of the literature.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Bacteriological Techniques; Ceftazidime; Conjunctiva; Cornea; Drug Therapy, Combination; Endophthalmitis; Humans; Infusions, Intravenous; Injections; Male; Necrosis; Ophthalmic Solutions; Pasteurella Infections; Pasteurella multocida; Phacoemulsification; Postoperative Complications; Vancomycin; Vitreous Body | 2005 |
A microbiological and confocal microscopy study documenting a slime-producing Staphylococcus epidermidis isolated from a nylon corneal suture of a patient with antibiotic-resistant endophthalmitis.
Topics: Aged; Anti-Bacterial Agents; Aqueous Humor; Bacteriological Techniques; Biofilms; Cornea; Corneal Injuries; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Eye Injuries, Penetrating; Humans; Male; Microscopy, Confocal; Nylons; Staphylococcal Infections; Staphylococcus epidermidis; Sutures; Vancomycin; Vitreous Body | 2005 |
Staphylococcus hominis endophthalmitis associated with a capsular hypopyon.
Topics: Amikacin; Chronic Disease; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Staphylococcal Infections; Staphylococcus hominis; Suppuration; Vancomycin; Vitreous Body | 2005 |
Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Disease Susceptibility; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Male; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Triamcinolone Acetonide; Vancomycin; Vitreous Body | 2005 |
Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Chloramphenicol; Chloramphenicol Resistance; Conjunctiva; Endophthalmitis; Humans; Microbial Sensitivity Tests; Nasolacrimal Duct; Nasopharynx; Surgical Wound Infection; Vancomycin; Vancomycin Resistance; Viridans Streptococci | 2005 |
In vitro influence of vancomycin on adhesion of a Staphylococcus epidermidis strain encoding intercellular adhesion locus ica to intraocular lenses.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Colony Count, Microbial; Drug Delivery Systems; Endophthalmitis; Lenses, Intraocular; Silicone Elastomers; Staphylococcus epidermidis; Time Factors; Vancomycin | 2005 |
Ocular hypersensitivitiy to topical vancomycin in a case of chronic endophthalmitis.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Chronic Disease; Drug Hypersensitivity; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Ophthalmic Solutions; Propionibacterium acnes; Vancomycin | 2005 |
Serratia marcescens endophthalmitis after cataract surgery despite vancomycin and gentamicin in irrigation fluid.
Topics: Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Humans; Phacoemulsification; Postoperative Complications; Serratia Infections; Serratia marcescens; Therapeutic Irrigation; Vancomycin | 2005 |
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Topics: Animals; Anterior Chamber; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Injections; Moxifloxacin; No-Observed-Adverse-Effect Level; Ophthalmic Solutions; Quinolines; Rabbits; Safety; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2005 |
Endophthalmitis after microincision cataract surgery.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Intraocular Pressure; Male; Microbial Sensitivity Tests; Microsurgery; Middle Aged; Phacoemulsification; Postoperative Complications; Streptococcal Infections; Streptococcus; Vancomycin; Vitrectomy | 2005 |
Bilateral endogenous endophthalmitis in a patient with hemoglobin SC disease.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Functional Laterality; Hemoglobin SC Disease; Humans; Middle Aged; Pneumococcal Infections; Vancomycin; Vitrectomy | 2005 |
Ocular infection secondary to gemella.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Staphylococcaceae; Tobramycin; Vancomycin | 2006 |
Subretinal abscess and endogenous endophthalmitis caused by beta-lactamase-positive Moraxella species.
Topics: Abscess; Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Endophthalmitis; Female; Humans; Middle Aged; Moraxella; Moraxellaceae Infections; Retinal Diseases; Vancomycin; Vitreous Body | 2006 |
Preparation of vancomycin microparticles: importance of preparation parameters.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Endophthalmitis; Particle Size; Polyglactin 910; Research Design; Solubility; Vancomycin | 2006 |
Endophthalmitis after 25-gauge transconjunctival sutureless vitrectomy.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Conjunctiva; Drug Therapy, Combination; Endophthalmitis; Female; Glucocorticoids; Humans; Needles; Prednisolone; Suture Techniques; Vancomycin; Vitrectomy | 2006 |
Pediatric endogenous bacterial endophthalmitis: case report and review of the literature.
Topics: Anti-Bacterial Agents; Blindness; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Vancomycin; Vitreous Body | 2006 |
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2007 |
Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Endophthalmitis; Female; Gram-Positive Bacteria; Humans; Injections; Male; Microbial Sensitivity Tests; Middle Aged; Phacoemulsification; Postoperative Complications; Vancomycin | 2007 |
In vitro efficacy of newly designed vancomycin-based microparticles.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Adhesion; Biocompatible Materials; Colony Count, Microbial; Drug Carriers; Endophthalmitis; Lactic Acid; Lenses, Intraocular; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Staphylococcus epidermidis; Vancomycin | 2007 |
Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Aza Compounds; Colony Count, Microbial; Dexamethasone; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edema; Endophthalmitis; Fluoroquinolones; Hyperemia; Injections; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2007 |
Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Penicillin G; Vancomycin; Vancomycin Resistance; Vitreous Body | 2007 |
Posttraumatic endophthalmitis due to a rare pathogen, Alcaligenes faecalis.
Topics: Alcaligenes faecalis; Ceftazidime; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Gram-Negative Bacterial Infections; Humans; Lens, Crystalline; Male; Vancomycin; Vitrectomy; Vitreous Body; Wound Infection | 2007 |
Endogenous group B streptococcal endophthalmitis in a preterm infant.
Topics: Adult; Anti-Bacterial Agents; Diagnosis, Differential; Endophthalmitis; Female; Humans; Infant, Newborn; Infant, Premature; Male; Pregnancy; Streptococcal Infections; Streptococcus agalactiae; Twins; Vancomycin; Vitrectomy | 2007 |
Bilateral endogenous endophthalmitis after holmium laser lithotripsy.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ceftazidime; Ceftriaxone; Cephalexin; Drug Therapy, Combination; Endophthalmitis; Female; Gentamicins; Holmium; Humans; Lithotripsy, Laser; Middle Aged; Pseudomonas Infections; Ureteral Calculi; Urinary Tract Infections; Vancomycin | 2007 |
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftazidime; Cornea; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Middle Aged; Phacoemulsification; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Time Factors; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Treatment Outcome; Vancomycin; Vitrectomy | 2008 |
Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Cataract Extraction; Endophthalmitis; Female; Fluoroquinolones; Gentamicins; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Postoperative Complications; Retrospective Studies; Staphylococcus aureus; Treatment Outcome; Vancomycin; Visual Acuity; Vitreous Body | 2008 |
Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Female; Levofloxacin; Male; Microbial Sensitivity Tests; Models, Animal; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin; Vitreous Body | 2008 |
Endophthalmitis caused by Bacillus species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacillus; Cephalosporins; Child; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 2008 |
Physicochemical properties and antibacterial activity of the precipitate of vancomycin and ceftazidime: implications in the management of endophthalmitis.
Topics: Anti-Bacterial Agents; Biological Availability; Ceftazidime; Chemical Precipitation; Chromatography, High Pressure Liquid; Drug Combinations; Endophthalmitis; Escherichia coli; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Spectrometry, Fluorescence; Staphylococcus aureus; Vancomycin | 2008 |
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Imipenem; Injections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2008 |
Incidence of endophthalmitis following vitreoretinal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; United Kingdom; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
Toward improving therapeutic regimens for Bacillus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillus cereus; Biological Availability; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Glucocorticoids; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Retina; Vancomycin; Vitreous Body | 2008 |
Treatment of postcataract extraction endophthalmitis: a summary of the results from the Endophthalmitis Vitrectomy Study.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Male; Multicenter Studies as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Vancomycin use in ophthalmology.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Utilization; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Ophthalmic Solutions; Ophthalmology; Vancomycin | 1995 |
Minimum bactericidal concentrations of Propionibacterium acnes isolates from cases of chronic endophthalmitis.
Topics: Anti-Bacterial Agents; Cefazolin; Chronic Disease; Endophthalmitis; Humans; Microbial Sensitivity Tests; Penicillins; Propionibacterium acnes; Sensitivity and Specificity; Vancomycin | 1995 |
Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Pneumococcal Infections; Rabbits; Random Allocation; Streptococcus pneumoniae; Vancomycin; Vitreous Body | 1995 |
Vancomycin levels in the vitreous cavity after intravenous administration.
Topics: Animals; Aphakia, Postcataract; Endophthalmitis; Injections, Intravenous; Rabbits; Vancomycin; Vitrectomy; Vitreous Body | 1995 |
Toxic retinopathy secondary to repeat intravitreal amikacin and vancomycin.
Topics: Amikacin; Child; Endophthalmitis; Eye Injuries, Penetrating; Humans; Male; Retinal Diseases; Vancomycin | 1994 |
[Bacterial endophthalmitis].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Endophthalmitis; Female; Humans; Klebsiella Infections; Male; Middle Aged; Prognosis; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Vitrectomy | 1994 |
Vancomycin in corneal transplantation.
Topics: Bacteria; Colony Count, Microbial; Cornea; Corneal Transplantation; Endophthalmitis; Gentamicins; Humans; Ophthalmic Solutions; Penicillins; Therapeutic Irrigation; Tissue Donors; Vancomycin | 1993 |
Intraocular ceftazidime as an alternative to the aminoglycosides in the treatment of endophthalmitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Child; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Vancomycin | 1994 |
Empiric treatment of endophthalmitis. Are aminoglycosides necessary?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Ceftazidime; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Postoperative Complications; Vancomycin | 1994 |
Antibacterial concentrations.
Topics: Cataract Extraction; Disinfection; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Humans; Therapeutic Irrigation; Vancomycin | 1993 |
Physical incompatibility of vancomycin and ceftazidime for intravitreal injection.
Topics: Animals; Ceftazidime; Drug Incompatibility; Endophthalmitis; Injections; Macaca; Retina; Vancomycin; Vitreous Body | 1993 |
Vancomycin levels after intravitreal injection. Effects of inflammation and surgery.
Topics: Animals; Anti-Bacterial Agents; Endophthalmitis; Half-Life; Injections; Lens, Crystalline; Linear Models; Rabbits; Staphylococcus epidermidis; Vancomycin; Vitrectomy; Vitreous Body | 1995 |
Coagulase-negative Staphylococcus endophthalmitis after cataract surgery with intraocular vancomycin.
Topics: Acute Disease; Aged; Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Coagulase; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Lenses, Intraocular; Male; Microbial Sensitivity Tests; Postoperative Complications; Staphylococcal Infections; Staphylococcus; Vancomycin; Vitrectomy; Vitreous Body | 1996 |
Comparative treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefazolin; Cephalosporins; Combined Modality Therapy; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Methylprednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitrectomy; Vitreous Body | 1996 |
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pilot Projects; Random Allocation; Retinitis; Swine; Thienamycins; Vancomycin; Vitreous Body | 1996 |
Case of bacterial endophthalmitis caused by an Agrobacterium radiobacter-like organism.
Topics: Aged; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Opportunistic Infections; Rhizobium; Soil Microbiology; Species Specificity; Vancomycin | 1996 |
Parameter estimation and dosage adjustment in the treatment with vancomycin of methicillin-resistant Staphylococcus aureus ocular infections.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dacryocystitis; Dose-Response Relationship, Drug; Endophthalmitis; Eye Infections; Female; Humans; Infant; Methicillin Resistance; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Injuries, Penetrating; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Care; Prospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Visual Acuity | 1997 |
Management of endophthalmitis in a silicone oil-filled eye.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Humans; Laser Coagulation; Male; Middle Aged; Postoperative Complications; Retinal Detachment; Silicone Oils; Staphylococcal Infections; Vancomycin; Vitrectomy | 1997 |
Extrusion of an anterior chamber intraocular lens complicated by Haemophilus endophthalmitis.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Foreign-Body Migration; Haemophilus Infections; Haemophilus influenzae; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Vancomycin; Vitrectomy; Vitreous Body | 1998 |
Recurrent endophthalmitis after cataract surgery with a scleral-tunnel incision.
Topics: Administration, Topical; Aged; Cataract Extraction; Cefazolin; Cornea; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections; Keratitis; Recurrence; Sclera; Staphylococcal Infections; Staphylococcus; Suture Techniques; Vancomycin; Vitreous Body | 1998 |
Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Dexamethasone; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Injections; Ophthalmoscopy; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin; Vitreous Body | 1998 |
Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Chromatography, High Pressure Liquid; Endophthalmitis; Eye Infections, Bacterial; Half-Life; Rabbits; Staphylococcal Infections; Tissue Distribution; Vancomycin; Vitreous Body | 1998 |
Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Dermatitis, Atopic; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Male; Methicillin; Methicillin Resistance; Middle Aged; Retinal Detachment; Retrospective Studies; Scleral Buckling; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Injections, Intramuscular; Methylprednisolone; Rabbits; Retina; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis.
Topics: Anti-Bacterial Agents; Biological Availability; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Vancomycin; Vitrectomy; Vitreous Body | 1999 |
Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Fluorescence Polarization Immunoassay; Glucocorticoids; Half-Life; Pneumococcal Infections; Rabbits; Random Allocation; Vancomycin; Vitreous Body | 1999 |
Treatment strategies for postoperative Propionibacterium acnes endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Propionibacterium acnes; Recurrence; Reoperation; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy | 1999 |
Vancomycin and ceftazidime incompatibility upon intravitreal injection.
Topics: Adolescent; Adult; Ceftazidime; Drug Incompatibility; Drug Therapy, Combination; Endophthalmitis; Humans; Injections, Intralesional; Male; Vancomycin | 2000 |
Epidemic Bacillus endophthalmitis after cataract surgery II: chronic and recurrent presentation and outcome.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus; Chronic Disease; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2000 |
Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillaceae Infections; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Injections; Rabbits; Random Allocation; Vancomycin; Vitreous Body | 2000 |
Propionibacterium acnes endophthalmitis requiring intraocular lens removal after failure of medical therapy.
Topics: Anti-Bacterial Agents; Device Removal; Endophthalmitis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Middle Aged; Phacoemulsification; Propionibacterium acnes; Prosthesis-Related Infections; Reoperation; Vancomycin; Visual Acuity | 2000 |
Pharmacokinetics of 0.5 mg of a single and a multiple dose of intravitreal vancomycin in infected rabbit eyes.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Endophthalmitis; Eye Infections, Bacterial; Half-Life; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Vancomycin; Vitreous Body | 2000 |
Acute bacterial endophthalmitis after cataract extraction: results of treatment.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cataract Extraction; Ceftazidime; Conjunctiva; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Middle Aged; Prognosis; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Surgical Wound Infection; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2000 |
[Treatment of chronic pseudophakic endophthalmitis after cataract surgery].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Female; Humans; Male; Middle Aged; Reoperation; Retrospective Studies; Vancomycin; Vitrectomy | 2000 |
Postoperative Proprionobacterium acnes endophthalmitis.
Topics: Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Postoperative Complications; Propionibacterium acnes; Retrospective Studies; Therapeutic Irrigation; Vancomycin | 2001 |
Translimbal approach for intravitreal injection in endophthalmitis after phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anesthesia, Local; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections; Limbus Corneae; Male; Phacoemulsification; Pseudomonas Infections; Vancomycin; Vitreous Body | 2001 |
Intraocular vancomycin levels after intravitreal injection in post cataract extraction endophthalmitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Middle Aged; Staphylococcal Infections; Streptococcal Infections; Time Factors; Tissue Distribution; Vancomycin; Vitreous Body | 2001 |
Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Adhesion; Ciprofloxacin; Clindamycin; Conjunctiva; Endophthalmitis; Epithelial Cells; Gentamicins; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microbial Sensitivity Tests; Postoperative Complications; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2001 |
Postoperative proprionibacterium acnes endophthalmitis.
Topics: Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Injections; Lens Capsule, Crystalline; Propionibacterium acnes; Vancomycin | 2001 |
Intravitreal antibiotics: the emergency kit.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Vancomycin; Vitreous Body | 2001 |
Corticosteroid and antibiotic therapy for bacillus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Bacillaceae Infections; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Vancomycin | 2001 |
Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Cataract Extraction; Colony Count, Microbial; Endophthalmitis; Female; Fluorescence Polarization Immunoassay; Gentamicins; Humans; Injections; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Vancomycin; Vitreous Body | 2001 |
An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis.
Topics: Anti-Bacterial Agents; Biological Availability; Body Temperature; Ceftazidime; Cephalosporins; Chemical Precipitation; Chromatography, High Pressure Liquid; Dialysis; Dialysis Solutions; Drug Combinations; Drug Stability; Endophthalmitis; Eye Infections, Bacterial; Humans; Hydrogen-Ion Concentration; Ophthalmic Solutions; Vancomycin; Vitreous Body | 2002 |
Delayed endophthalmitis in a child following an Ahmed glaucoma valve implant.
Topics: Cataract; Cataract Extraction; Ceftazidime; Child; Dexamethasone; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Glaucoma; Glaucoma Drainage Implants; Haemophilus Infections; Haemophilus influenzae; Humans; Intraocular Pressure; Prosthesis Implantation; Vancomycin; Vitrectomy; Vitreous Body | 2002 |
Experimental postoperative endophthalmitis.
Topics: Animals; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Microbial Sensitivity Tests; Postoperative Complications; Rabbits; Vancomycin | 1992 |
Treatment of endophthalmitis.
Topics: Amphotericin B; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Humans; Mycetoma; Pseudallescheria; Vancomycin | 1992 |
Filters and antibiotics in irrigating solution for cataract surgery.
Topics: Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Filtration; Gentamicins; Humans; Premedication; Therapeutic Irrigation; Vancomycin | 1991 |
Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis.
Topics: Animals; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Injections; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vitreous Body | 1991 |
Delayed-onset pseudophakic endophthalmitis.
Topics: Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Lenses, Intraocular; Prednisolone; Propionibacterium acnes; Recurrence; Vancomycin; Vitrectomy | 1991 |
Bacillus-induced endophthalmitis.
Topics: Anti-Bacterial Agents; Bacillus; Bacterial Infections; Clindamycin; Endophthalmitis; Gentamicins; Humans; Vancomycin | 1991 |
Gentamicin-resistant streptococcal endophthalmitis after keratoplasty.
Topics: Adult; Child; Child, Preschool; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Gentamicins; Glycopeptides; Humans; Keratoplasty, Penetrating; Male; Pneumococcal Infections; Preservation, Biological; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1990 |
Endocapsular hypopyon: a clinical sign of localized endophthalmitis.
Topics: Aged; Anterior Chamber; Cefazolin; Chronic Disease; Corynebacterium Infections; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Capsule, Crystalline; Lens, Crystalline; Lenses, Intraocular; Suppuration; Vancomycin | 1990 |
Rural endophthalmitis.
Topics: Adolescent; Adult; Aged; Bacteria; Chi-Square Distribution; Child; Clindamycin; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Gentamicins; Humans; Iowa; Male; Middle Aged; Prognosis; Retrospective Studies; Rural Health; Vancomycin; Visual Acuity | 1989 |
Late endophthalmitis after transscleral fixation of a posterior chamber intraocular lens.
Topics: Adult; Endophthalmitis; Eye Injuries; Gentamicins; Haemophilus Infections; Humans; Lenses, Intraocular; Male; Sutures; Vancomycin; Visual Acuity; Vitreous Body | 1989 |
Coagulase-negative staphylococcal endophthalmitis. Increase in antimicrobial resistance.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Resistance, Microbial; Endophthalmitis; Gentamicins; Humans; Male; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin.
Topics: Animals; Drug Evaluation; Endophthalmitis; Humans; Injections; Methicillin; Microscopy, Electron; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Vitreous Body | 1986 |
Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin.
Topics: Animals; Aphakia, Postcataract; Drug Synergism; Drug Therapy, Combination; Endophthalmitis; Gentamicins; Lenses, Intraocular; Pigment Epithelium of Eye; Rabbits; Retina; Vancomycin; Vitrectomy; Vitreous Body | 1987 |
Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin.
Topics: Endophthalmitis; Humans; Injections; Methicillin; Penicillin Resistance; Staphylococcal Infections; Vancomycin; Vitreous Body | 1987 |